Cardiocore Consortium Wins 10-Year, $20B National Institutes of Health Contract
09.July.2012; Washington, DC-Cardiocore, a premier centralized cardiac testing laboratory and technology provider, announced today that its consortium has been awarded the coveted Chief Information Officer-Solutions and Partners 3 (CIO-SP3) Government Wide Acquisition Contract (GWAC). This contract, sponsored by the National Institutes of Health (NIH), is valued at $20 billion over a 10-year term.
Led by Creative Information Technology (CITI), Cardiocore’s team also includes ICON Medical Imaging and Zimmerman Associates (ZAI). These organizations are joined through a Contractor Team Agreement (CTA). In total, the NIH’s CIO-SP3 indefinite delivery/indefinite quantity (ID/IQ) program comprises approximately 50 contractors, serving a wide range of government agencies, with particular focus on Biomedical Research, Health Sciences, and Healthcare work orders.
"We are very pleased that our team has been selected by the NIH for this landmark CIO-SP3 award," said Scott Satin, Cardiocore’s Vice President of Marketing. "We look forward to expanding our NIH and other government-sponsored services in the decade ahead, and we are delighted to be part of such a well-qualified, well-experienced coalition."
Putting Collective Insights Into Action to Advance Cancer Care: Key Examples From ASCO 2025
June 27th 2025At ASCO 2025, clinical operations leaders gained critical insights into how AI tools, bispecific antibodies, and evolving treatment paradigms are reshaping trial design, endpoint selection, and patient stratification.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Funding Cuts Threaten Diversity in Clinical Research
June 27th 2025In this video interview, Kyle McAllister, co-founder, CEO, Trially, discusses how recent federal funding cuts are likely to undermine research focused on underrepresented populations, and why long-term investment in community-based studies is essential to closing persistent health equity gaps.
